Skip to main content

Table 1 Clinical and demographic characteristics of patients and healthy controls

From: Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control

  Rheumatoid arthritis patients Non-inflammatory joint disease patients Healthy controls
Patients 62 33 45
Age (years ± standard deviation) 61.8 ± 13.9 43.0 ± 18.0 54.4 ± 9.0
Sex (male/female) 18/44 20/13 2/43
Disease duration (years ± standard deviation) 10.1 ± 8.5   
Rheumatoid factor (+/-) 38/24   
Radiographic changes (erosive/non-erosive) 39/23   
Treatment (DMARD/no DMARD) 36/26   
  1. DMARD, disease-modifying anti-rheumatic drug.